High
blood glucose level rather than insulin status is linked with early
coronary artery disease in young diabetic adults
High blood glucose levels rather than
insulin status (insulin deficiency versus insulin resistance) is
associated with coronary artery disease in younger adults with diabetes,
according to an article in the April 16th issue of the Journal of
the American College of Cardiology. Researchers found that patients’
coronary arteries responded similarly to vascular function tests
regardless of whether the underlying diabetes was Type 1 or Type
2.
"We noticed that the two groups were
very similar in a number of different measurements we performed
[with positron emission tomographic imaging] with respect to blood
flow, coronary resistance and so on; so our interpretation of the
data is that, because the only thing these two groups have in common
is hyperglycemia, then the hyperglycemia is probably the primary
culprit for the abnormalities that one sees," said Marcelo
F. Di Carli, MD, lead author of the study.
The current study was designed to investigate
the relative importance of insulin (Type 1 or Type 2 diabetes) and
chronic hyperglycemia in the early stages of microvascular coronary
disease.
"The primary purpose of the study was
to look at the fundamental level of the regulation of coronary blood
flow as a marker of early atherosclerosis in diabetic patients.
In essence, it's a pretty simple study, we just picked two different
models to account for the effects of insulin," Di Carli said.
The researchers enrolled 18 people with Type
1 diabetes, 17 people with Type 2 diabetes, and 11 healthy people
as a control group. The two groups of people with diabetes were
similar in age and control of blood glucose levels. Researchers
observed blood flow in the hearts of participants with use of positron
emission tomography and then used adenosine and cold stress to trigger
different types of vessel dilation.
Evaluation of patients with both types of
diabetes allowed researchers to test the importance of insulin.
Significant differences between the groups would have suggested
that pathogenesis of microvascular disease involved different levels
of and cellular responses to insulin.
The researchers concluded that chronic hyperglycemia
plays a major role in pathogenesis of vascular dysfunction because
there were no differences in findings between the groups with Type
1 and Type 2 diabetes, only between the diabetic patients and the
healthy controls: Differences in response to adenosine-induced hyperemia
and cold pressor testing between the adults with diabetes and the
control group persisted after adjustment for factors including duration
of diabetes, insulin treatment, metabolic abnormalities, and autonomic
neuropathy.
This study helps to close the gap between
existing experimental evidence of the toxic effects of glucose on
vascular endothelium and clinical studies showing that control of
blood glucose levels postpones complications of diabetes such as
atherosclerosis and myocardial infarction.
"We know diabetic patients have higher
rates of heart attack and other problems, but the process begins
much earlier in life, so that's another feature that's kind of scary,
because even when patients are in their 30s you can already see
these impaired coronary blood flows as an early sign of atherosclerosis.
It's both an interesting and a worrisome finding," said Di
Carli.
Rory Hachamovitch, MD, who was not part of
the research team, said that the study findings will bring new attention
to the role of glucose.
"In the medical community, there has
been an increasing awareness of the importance of insulin resistance
as primary driver of premature atherosclerosis in diabetes mellitus,
as well as in patients with ‘prediabetic’ states. The role of hyperglycemia
in the pathophysiology of macrovascular disease, on the other hand,
was not felt to be significant," he said, adding that this
study will help direct future research.
"The results of the study by Di Carli
et al indicate that glycemic control needs to be considered along
with prevention or reversal of insulin resistance in the management
of patients, but the prognostic implications of these approaches
need to be evaluated."
|